Cefadroxil
- Product NDC
- 68289-051
- 11-digit product format
- 682890051
- Labeler code
- 68289
- Product ID
- 68289-051_9818cae1-268b-4c1f-8ab2-c5d33b574d01
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefadroxil
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Jazeera Pharmaceutical
- Application
- ANDA065311
- Marketing category
- ANDA
- Marketing start
- 2006-02-07
- Marketing end
- 0000-00-00
- Substance
- CEFADROXIL
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68289-051-01 | 2023-11-29 | C162847 | 48780-1 | ba0f9c33-4aae-a910-e053-dadaa90a0b85 | cc31a6f2-bff0-4798-b67e-06caa1bf7516 |
| 68289-051-22 | 2023-11-29 | C162847 | 48780-1 | ba0f9c33-4aae-a910-e053-dadaa90a0b85 | cc31a6f2-bff0-4798-b67e-06caa1bf7516 |
| 68289-051-50 | 2023-11-29 | C162847 | 48780-1 | ba0f9c33-4aae-a910-e053-dadaa90a0b85 | cc31a6f2-bff0-4798-b67e-06caa1bf7516 |
| 68289-051-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4aae-a910-e053-dadaa90a0b85 | cc31a6f2-bff0-4798-b67e-06caa1bf7516 |
| 68289-051-22 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4aae-a910-e053-dadaa90a0b85 | cc31a6f2-bff0-4798-b67e-06caa1bf7516 |
| 68289-051-50 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4aae-a910-e053-dadaa90a0b85 | cc31a6f2-bff0-4798-b67e-06caa1bf7516 |